Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03595917
Title ABL001 + Dasatinib + Prednisone in BCR-ABL+ B-ALL or CML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Marlise R. Luskin
Indications

chronic myeloid leukemia

childhood B-cell acute lymphoblastic leukemia

Therapies

Asciminib + Dasatinib + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.